Capital raised by Goldenrod Therapeutics
1 Form D filing · first filed May 2026 · Houston, TX
Director
Listed on Goldenrod Therapeutics's Form D filings
Mark Worscheh is on file as Director at Goldenrod Therapeutics in Houston, TX. Goldenrod Therapeutics has 1 Form D filing on record, $3.2M raised in total.
A brain-penetrant small-molecule PDE4 inhibitor targeting neuroinflammation and neuronal signaling, headed toward a Phase I study with Friedreich's ataxia as the lead indication.
